MicroRNA-379 inhibits the proliferation, migration and invasion of human osteosarcoma cells by targetting EIF4G2

Bioscience Reports - Tập 37 Số 3 - 2017
Xi Xie1,2, Yusheng Li2, Wenfeng Xiao2, Zhenhan Deng2, Hongbo He2, Qing Liu2, Wei Luo2
1Department of Day Surgery Center, Xiangya Hospital, Central South University, Changsha 410008, P.R. China
2Department of Orthopedics, Xiangya Hospital, Central South University, Changsha 410008, P.R. China

Tóm tắt

Osteosarcoma (OS) is an aggressive malignant mesenchymal neoplasm amongst adolescents. The aim of the present study was to explore the various modes of action that miR-379 has on the proliferation, migration, and invasion of human OS cells. miR-379 achieves this by targetting eukaryotic initiation factor 4GII (EIF4G2). Human OS cell lines U2OS and MG-63 were selected and assigned into blank, miR-379 mimics, miR-379 mimic negative control (NC), miR-379 inhibitors, miR-379 inhibitor NC, EIF4G2 shRNA, control shRNA, and miR-379 inhibitor + EIF4G2 shRNA group. The miR-379 expression and EIF4G2 mRNA expression were detected utilising quantitative real-time PCR (qRT-PCR) and the EIF4G2 protein expression using Western blotting. MTT assay, scratch test, Transwell assay, and flow cytometry were performed to determine the proliferation, migration, invasion, and cell cycle, respectively. In comparison with the miR-379 mimic NC group, the miR-379 mimics group had decreased EIF4G2 expression; the miR-379 inhibitors group indicated an increased EIF4G2 expression. Compared with the control shRNA group, the EIF4G2 expression was lower in the EIF4G2 shRNA group and the miR-379 expression was dropped in the miR-379 inhibitor + EIF4G2 shRNA group. The proliferation, migration, and invasion abilities of OS cells were reduced in the miR-379 mimics and EIF4G2 shRNA groups. The percentage of OS cells at the G0/G1 stage was increased, and the percentage at the S-stage was decreased in the miR-379 mimics and EIF4G2 shRNA groups. miR-379 may inhibit the proliferation, migration and invasion of OS cells through the down-regulation of EIF4G2.

Từ khóa


Tài liệu tham khảo

Kobayashi, 2012, MicroRNA involvement in osteosarcoma, Sarcoma, 2012, 359739, 10.1155/2012/359739

Ottaviani, 2009, The etiology of osteosarcoma, Cancer Treat. Res., 152, 15, 10.1007/978-1-4419-0284-9_2

Hattinger, 2015, Advances in emerging drugs for osteosarcoma, Expert Opin. Emerg. Drugs, 20, 495, 10.1517/14728214.2015.1051965

Geller, 2010, Osteosarcoma: a review of diagnosis, management, and treatment strategies, Clin. Adv. Hematol. Oncol, 8, 705

Wu, 2016, MiR-429 reverses epithelial-mesenchymal transition by restoring E-cadherin expression in bladder cancer, Oncotarget, 7, 26593, 10.18632/oncotarget.8557

Zhou, 2013, MicroRNAs in osteosarcoma: from biological players to clinical contributors, a review, J. Int. Med. Res., 41, 1, 10.1177/0300060513475959

Chen, 2015, Mir-664 promotes osteosarcoma cells proliferation via downregulating of FOXO4, Biomed. Pharmacother., 75, 1, 10.1016/j.biopha.2015.08.012

Waresijiang, 2016, The downregulation of miR125a5p functions as a tumor suppressor by directly targeting MMP11 in osteosarcoma, Mol. Med. Rep., 13, 4859, 10.3892/mmr.2016.5141

Bhattacharya, 2016, Increased miR-155-5p and reduced miR-148a-3p contribute to the suppression of osteosarcoma cell death, Oncogene, 35, 5282, 10.1038/onc.2016.68

Chen, 2016, MicroRNA-379-5p inhibits tumor invasion and metastasis by targeting FAK/AKT signaling in hepatocellular carcinoma, Cancer Lett., 375, 73, 10.1016/j.canlet.2016.02.043

Gururajan, 2014, miR-154* and miR-379 in the DLK1-DIO3 microRNA mega-cluster regulate epithelial to mesenchymal transition and bone metastasis of prostate cancer, Clin. Cancer Res., 20, 6559, 10.1158/1078-0432.CCR-14-1784

Haga, 2012, MicroRNAs in the imprinted DLK1-DIO3 region repress the epithelial-to-mesenchymal transition by targeting the TWIST1 protein signaling network, J. Biol. Chem., 287, 42695, 10.1074/jbc.M112.387761

Josson, 2014, miR-409-3p/-5p promotes tumorigenesis, epithelial-to-mesenchymal transition, and bone metastasis of human prostate cancer, Clin. Cancer Res., 20, 4636, 10.1158/1078-0432.CCR-14-0305

Wu, 2016, MicroRNA-409-3p inhibits osteosarcoma cell migration and invasion by targeting catenin-delta1, Gene, 584, 83, 10.1016/j.gene.2016.03.021

Luo, 2008, Osteogenic BMPs promote tumor growth of human osteosarcomas that harbor differentiation defects, Lab. Invest., 88, 1264, 10.1038/labinvest.2008.98

Zheng, 2015, MicroRNA-26b inhibits osteosarcoma cell migration and invasion by down-regulating PFKFB3 expression, Genet. Mol. Res., 14, 16872, 10.4238/2015.December.14.14

Wang, 2016, MicroRNA-101 has a suppressive role in osteosarcoma cells through the targeting of c-FOS, Exp. Ther. Med., 11, 1293, 10.3892/etm.2016.3085

Zhang, 2016, MiR-30a regulates the proliferation, migration, and invasion of human osteosarcoma by targeting Runx2, Tumour Biol., 37, 3479, 10.1007/s13277-015-4086-7

Zhao, 2013, MicroRNAs as critical regulators involved in regulating epithelial- mesenchymal transition, Curr. Cancer Drug Targets, 13, 935, 10.2174/15680096113136660099

Lamouille, 2014, Molecular mechanisms of epithelial-mesenchymal transition, Nat. Rev. Mol. Cell Biol., 15, 178, 10.1038/nrm3758

Wang, 2016, Upregulation of H19 indicates a poor prognosis in gallbladder carcinoma and promotes epithelial-mesenchymal transition, Am. J. Cancer Res., 6, 15

Heerboth, 2015, EMT and tumor metastasis, Clin. Transl. Med., 4, 6, 10.1186/s40169-015-0048-3

Liu, 2016, Fluid shear stress induces epithelial-mesenchymal transition (EMT) in Hep-2 cells, Oncotarget, 7, 32876, 10.18632/oncotarget.8765

Liu, 2011, The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44, Nat. Med., 17, 211, 10.1038/nm.2284

Khan, 2013, miR-379 regulates cyclin B1 expression and is decreased in breast cancer, PLoS ONE, 8, e68753, 10.1371/journal.pone.0068753

Caron, 2004, Selective modification of eukaryotic initiation factor 4F (eIF4F) at the onset of cell differentiation: recruitment of eIF4GII and long-lasting phosphorylation of eIF4E, Mol. Cell Biol., 24, 4920, 10.1128/MCB.24.11.4920-4928.2004

Mazan-Mamczarz, 2014, Down-regulation of eIF4GII by miR-520c-3p represses diffuse large B cell lymphoma development, PLoS Genet., 10, e1004105, 10.1371/journal.pgen.1004105

Gradi, 1998, A novel functional human eukaryotic translation initiation factor 4G, Mol. Cell Biol., 18, 334, 10.1128/MCB.18.1.334

Imataka, 1998, A newly identified N-terminal amino acid sequence of human eIF4G binds poly(A)-binding protein and functions in poly(A)-dependent translation, EMBO J., 17, 7480, 10.1093/emboj/17.24.7480

Ruggero, 2004, The translation factor eIF-4E promotes tumor formation and cooperates with c-Myc in lymphomagenesis, Nat. Med., 10, 484, 10.1038/nm1042

Hagner, 2010, Targeting the translational machinery as a novel treatment strategy for hematologic malignancies, Blood, 115, 2127, 10.1182/blood-2009-09-220020

Horvilleur, 2010, Translation deregulation in B-cell lymphomas, Biochem. Soc. Trans., 38, 1593, 10.1042/BST0381593

Stumpf, 2011, The cancerous translation apparatus, Curr. Opin. Genet. Dev., 21, 474, 10.1016/j.gde.2011.03.007

Zhao, 2013, miR-34a inhibits the metastasis of osteosarcoma cells by repressing the expression of CD44, Oncol. Rep., 29, 1027, 10.3892/or.2013.2234

Maire, 2011, Analysis of miRNA-gene expression-genomic profiles reveals complex mechanisms of microRNA deregulation in osteosarcoma, Cancer Genet, 204, 138, 10.1016/j.cancergen.2010.12.012

Thông tin
Thông tin xuất bản

Bioscience Reports

Tập 37 Số 3

Thông tin tác giả